OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/18/2025
Back to search
Official data from USPTO
LIVAZEBE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
12/19/2025
Trademark type
Word
Nice classes
5
Filing date
05/31/2024
Registration date
12/24/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2024
Last transaction
12/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
SMITH,CAROLINE P
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
KOWA COMPANY, LTD.
Representatives
KOWA COMPANY, LTD.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationspharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseasespharmaceutical preparations for treatment of fatty liver and steatohepatitispharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorderspharmaceutical preparations for the treatment of digestive system diseasepharmaceutical preparations for the treatment of primary biliary cirrhosispharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosispharmaceutical preparations for the treatment of liver diseasepharmaceutical preparations for the treatment of metabolic diseasepharmaceutical preparations for the prevention and treatment of disorders of the metabolic systemanalgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous systemperipheral nervous systemsensory organsthe circulatory systemrespiratory systemthe digestive system; pharmaceutical substances for the treatment of dermatological diseasesallergies and urogenital or anal conditions; veterinary preparationsveterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseasesveterinary preparations for treatment of fatty liver and steatohepatitisveterinary preparations for the treatment of cardiovascular disorders and metabolic disordersveterinary preparations for the treatment of digestive system diseaseveterinary preparations for the treatment of primary biliary cirrhosisveterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosisveterinary preparations for the treatment of liver diseaseveterinary preparations for the treatment of metabolic diseaseveterinary preparations for the prevention and treatment of disorders of the metabolic systemanalgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous systemperipheral nervous systemsensory organsthe circulatory systemrespiratory systemthe digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseasesallergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agentstopical preparations in the form of gels and salvesadhesive skin patchesliquid formulationscream and spraysall for relieving pain.
Publications
History of USPTO decisions and trademark events.
13 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/23/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2024
PUBO
PUBLISHED FOR OPPOSITION
11/05/2024
NPUB
NOTICE OF PUBLICATION
10/16/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2024
DOCK
ASSIGNED TO EXAMINER
09/16/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/09/2024
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/05/2024
Continuous trademark protection
Get notified about every new filing that threatens LIVAZEBE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.